depression

Will microdosing become a new norm?

In May of this year, Fast Company reported employees at the mushroom coffee brand MUD\WTR added small amounts of hallucinogenic (psilocybin) mushrooms to their morning brew. Silicon Valley employees have long been rumoured to microdose psychedelics at work to enhance focus, creativity, and improve productivity. The popularity of microdosing has since grown among politicians and …

Will microdosing become a new norm? Read More »

Ketamine Wellness Centers Announces Partnership With the Veterans Administration in Arizona

Nation’s Largest Ketamine Therapy Provider to Cover Out-Of-Pocket Costs for Veterans Experiencing Treatment-Resistant Depression, PTSD and Anxiety Ketamine Wellness Centers (KWC), the largest ketamine therapy provider in the U.S. and a subsidiary of Delic Holdings Corp (“Delic”) announced a new partnership with the Veterans Administration (VA) in Arizona. Veterans suffering from treatment-resistant depression, PTSD and …

Ketamine Wellness Centers Announces Partnership With the Veterans Administration in Arizona Read More »

Madrigal Mental Care Develops Psychedelic Drug Treatment for Post-Traumatic Stress Disorder

Novel Nasal-Spray Nano-Formulation Enables Nose-To-Brain Delivery of Biodegradable Nanoparticles that can Encapsulate Psychedelic Substances such as Psilocybin Madrigal Mental Care, a biopharmaceutical company developing a breakthrough delivery system for psychedelic drugs, introduced its novel nanotechnology for the treatment and prevention of post-traumatic stress disorder (PTSD) at Biomed Israel 2022, the premier international Life Science and …

Madrigal Mental Care Develops Psychedelic Drug Treatment for Post-Traumatic Stress Disorder Read More »

Studies show psilocybin therapy has potential for anorexia nervosa and severe treatment-resistant depression

Positive Early Signals Seen in Two Investigator-Initiated Studies Presented at the Society of Biological Psychiatry Annual Meeting in New Orleans COMPASS Pathways (COMPASS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced that positive data two investigator-initiated studies demonstrating the potential of COMP360 psilocybin therapy in anorexia …

Studies show psilocybin therapy has potential for anorexia nervosa and severe treatment-resistant depression Read More »

LSD: A Future Anti-Anxiety Pill?

New Study by Dr. Gabriella Gobbi Reveals the Neurobiological Mechanisms by which LSD could Relieve Anxiety The craze for psychedelics used for therapeutic purposes is real. However, the scientific evidence supporting their effectiveness and explaining their mode of action in treating mental health disorders is still very thin. A new study led by Dr. Gabriella …

LSD: A Future Anti-Anxiety Pill? Read More »

Study Shows Psilocybin Treatment for Major Depression Effective for Up to a Year for Most Patients

Previous studies by Johns Hopkins Medicine researchers showed that psychedelic treatment with psilocybin relieved major depressive disorder symptoms in adults for up to a month. Now, in a follow-up study of those participants, the researchers report that the substantial antidepressant effects of psilocybin-assisted therapy, given with supportive psychotherapy, may last at least a year for some patients. …

Study Shows Psilocybin Treatment for Major Depression Effective for Up to a Year for Most Patients Read More »

Monash University-Led Team Receives Funding for Psychedelic Psychotherapy in Treatment-Resistant Depression

The Medical Research Future Fund Clinical Trials Activity Initiative has awarded $2.7M for Innovative Therapies for Mental Illness to a Monash University-led team, to evaluate the efficacy of psilocybin-assisted psychotherapy in treatment-resistant depression. Major Depressive Disorder (MDD) is, sadly, common, and results in the greatest global burden of disease. Although there are established treatments for …

Monash University-Led Team Receives Funding for Psychedelic Psychotherapy in Treatment-Resistant Depression Read More »

Using psychedelics for terminal illness and end of life

Death is the one thing all humans have in common, and everyone deserves to end their lives with dignity. There are several physical, mental, and emotional symptoms those at the end of life can face depending on their condition: pain, dyspnea (shortness of breath), mental confusion or delirium, agitation (also known as terminal restlessness), and …

Using psychedelics for terminal illness and end of life Read More »

Using Psychoactive Plants and Fungi for Long-Term Mental Wellness

By Raley Anne James According to a mental health organization, one in five adults in the U.S. experience having a mental illness each year. These include serious mental health conditions such as anxiety disorders, major depressive episodes, and post-traumatic stress disorder. Despite the various organizations trying to counter these issues to increase mental health awareness and …

Using Psychoactive Plants and Fungi for Long-Term Mental Wellness Read More »

Scroll to Top